Metformin significantly reduces pain in non-diabetic patients with osteoarthritis of the knee.

Metformin eased knee osteoarthritis pain more than placebo in a 6-month Australian RCT
Luigi Fontana's summary of a JAMA RCT in people with knee osteoarthritis and overweight/obesity: metformin reduced pain more than placebo. He frames it as aging biology (AMPK, mTOR, inflammation) as a treatment target, and notes lifestyle approaches like caloric restriction act on the same pathways. Little direct heart relevance.


